$0.32
▲ +2.0% Today
as of Jul 22, 16:46 ET
Last 30 days
Recent Press Releases & News
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX)
Overview
52-week range
$0.16
$2.04
9% of range
Avg surprise (last 3)
-3.8%
Avg reaction (last 2)
+0.7%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.19 | $-0.30 | +36.7% | +66.1% | +1.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.33 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.30 | $-0.41 | +26.8% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.56 | $-0.32 | -75.0% | — | -0.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.13 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.50 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.33 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.39 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.47 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$0.15 | -$0.30 | +50.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $7,385 | — | $10,570 | $8,729 | $2,909 | — | $18,243 | $6,490 |
| Gross profit | $15,785 | — | $1,230 | $294,571 | $22,091 | — | $215,357 | $82,610 |
| Operating income | $-3M | — | $-4M | $-3M | $-5M | — | $-2M | $-2M |
| Net income | $-2M | — | $-3M | $-3M | $-5M | — | $-1M | $-4M |
| EPS (diluted) | $-0.12 | — | $-0.33 | $-0.30 | $-0.64 | — | $-0.13 | $-0.50 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3M | $2M | $602,444 | $2M | $1M | $547,890 | $1M | $2M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $4M | $3M | $5M | $8M | $9M | $11M | $14M | $15M |
| Total assets | $5M | $4M | $6M | $9M | $10M | $12M | $15M | $16M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | $4M | $4M | $4M | $5M | $5M |
| Total equity | $3M | $356,744 | $2M | $5M | $6M | $9M | $10M | $11M |
Implied volatility — last 90 days
No IV snapshots yet for BRTX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.